MONTREAL, QUEBEC--(Marketwire - November 13, 2007) - ProMetic Life Sciences Inc. (TSX: PLI) (“ProMetic”) announced today that ProMetic’s abstract on its PBI-1402 Phase II clinical trial in patients with chemotherapy-induced anemia (“CIA”) is now available on the American Society of Hematology’s (“ASH”) Web site under the heading “Annual Meeting Abstracts” http://www.hematology.org/meetings/2007/index.cfm.
